For the last two years, the UK life sciences sector has demonstrated a real spirit of collaboration in an effort to tackle Covid-19. In an article published in Pharmaceutical Market Europe, Catherine Penny considers the extent to which the current political and economic climate coupled with the easing of supportive measures put in place by the UK Government may pave the way for an increase in life sciences disputes.
The full article is available here.